NAPLES, Fla., April 27 /PRNewswire/ -- Masimo, the innovator and leader of read-through motion and low perfusion pulse oximetry, today announced that the NCH Healthcare System, a 500-bed, 2-campus hospital specializing in cardiac care and oncology, has standardized on Masimo SET oximetry. The NCH conversion features an upgrade of the TRAM and DASH GE patient monitors to full Masimo SET capability, as well as the purchase of nearly 300 Masimo SET Radicals. NCH cited improved care at reduced costs as the principle motivation for conversion.
Scott Wiley, Director, Cardiopulmonary Services, said, "The house-wide conversion to Masimo SET technology was an easy decision for the NCH Healthcare System. It has enabled clinicians to better utilize pulse oximetry. With the motion sensitive technology, perfusion index, and Signal IQ, patient assessment and clinical accuracy has evolved. We now have a clearer understanding of the patient's oxygen saturation status without the guesswork. In terms of the conversion process, it was a committed effort by the Masimo staff. Their team provided us with the support and tools necessary to perform the upgrade."
Kevin Mosher, President, Masimo Americas, stated, "Naples Community Hospital has a reputation for outstanding patient care and a dedication to providing their patients with cutting-edge technology. We believe the 60,000-plus patients they see every year will benefit from the superior signal extraction technology Masimo provides."
About NCH Healthcare System
NCH Healthcare is an alliance of more than 550 physicians, 2 hospitals, and dozens of medical facilities in southwest Florida. NCH can be accessed through the internet at http://www.nchmd.org/.
About Masimo
Masimo, founded in 1989, is the innovator and leader of read-through motion and low perfusion pulse oximetry. Masimo develops, licenses, and markets advanced medical signal processing technologies and products for the non-invasive monitoring of vital signs. Masimo Signal Extraction Technology, or Masimo SET, represents the standard of care for pulse oximeters. Over 90 clinical studies support the conclusion that Masimo SET is the most effective pulse oximeter in the world. Masimo is headquartered in Irvine, California. Additional information about Masimo and its products can be found at http://www.masimo.com/.
Masimo is currently offering a $250,000 guarantee to hospitals seeking an upgrade to next generation pulse oximetry. If Masimo does not outperform Nellcor in an objective clinical trial, Masimo will pay that hospital $250,000 towards the purchase of Nellcor oximetry. Contact Masimo for more details.
MasimoCONTACT: Brad Langdale of Masimo Corporation, +1-949-253-6404,blangdale@masimo.com
Web site: http://www.nchmd.org/
Web site: http://www.masimo.com/